Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 AUD | +1.32% | +7.72% | +15.41% |
May. 08 | KKR to buy Perpetual's corporate, wealth units for $1.4 billion; CEO Adams to retire | RE |
Apr. 29 | Australian dental centres operator Pacific Smiles backs $198 mln bid from NDC | RE |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an enterprise value anticipated at 3.64 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.41% | 519M | - | ||
-3.68% | 116B | A- | ||
+7.89% | 98.79B | C+ | ||
+15.16% | 69.43B | - | B+ | |
+23.96% | 65.73B | C | ||
+13.53% | 44.19B | C+ | ||
+16.10% | 43.8B | A- | ||
+21.85% | 36.26B | A- | ||
+9.76% | 26.39B | B | ||
-2.67% | 22.71B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RPL Stock
- Ratings Regal Partners Limited